ProQR Therapeutics N.V. (NASDAQ: PRQR) today announced that it received Fast Track designation from the Food and Drug Administration (FDA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE